We use cookies for a better user experience. Read our Privacy Policy

I Agree

Women’s Health Diagnostics Market

Women’s Health Diagnostics Market (Device Type: Biopsy Devices, Imaging & Monitoring Systems, Kits & Reagents, and Consumables & Accessories; Test Type: Breast Cancer Testing, Cervical Cancer Testing, Prenatal Genetic Screening & Carrier Testing, Pregnancy Testing, Fertility & Ovulation Testing, Infectious Disease Testing, and Others; and End User: Hospitals, Diagnostic Laboratories & Imaging Centers, Specialty Clinics, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019 - 2027

Infections in Pregnant Women Drive Demand for Effective Women’s Health Diagnostics Solutions

High risks associated with the transmission of infectious diseases to pregnant women have raised concerns about the effective diagnosis of various infections. As such, the infectious disease testing type segment of the women’s health diagnostics market is projected to reach a value of ~US$ 19.2 Bn by the end of 2027. Hence, leading players in the market for women’s health diagnostics are increasing their efficacy in laboratory testing solutions to improve patient outcomes. For instance, leading global medical technology company Siemens Healthineers offers a range of laboratory testing solutions for women related to TORCH (toxoplasmosis, other (e.g., syphilis, HIV), rubella, cytomegalovirus (CMV), and herpes simplex virus) infections, malnutrition, and bone diseases.

Healthcare companies in the women’s health diagnostics market are tapping into opportunities in diagnostic laboratory testing and infectious disease testing, as both segments are anticipated to grow rapidly during the forecast period. The growing prevalence of infections causing miscarriage and birth defects in infants is fueling the demand for efficacious treatment options in women’s health diagnostics.

womens health diagnostics market infographic

To know the scope of our report Get a Sample on Point-of-Care Women’s Health Diagnostics Market 

Strategic Mergers Offer New Reproductive Health Solutions for Asian Women

Apart from expanding product portfolios, companies in the market for women’s health diagnostics are strengthening their global presence through inorganic strategies such as mergers and acquisitions. For instance, in August 2019, Nova Satra Dx - a provider of innovative diagnostics for cancer, announced its merger with a Singapore-based molecular diagnostic company INEX Innovations Exchange Pte. Ltd., to offer healthcare solutions tailored for Asian women. As such, Asia Pacific accounts for the third-highest revenue in the women’s health diagnostics market. This market in the Asia Pacific is anticipated for exponential growth during the forecast period.

Companies are collaborating to offer enhanced treatment options in the Asia Pacific. Efforts are being made to increase the availability of faster and more accurate diagnostic tests to improve the quality of life in patients. The concept of precision healthcare is another key driver that is creating incremental opportunities for companies. The women’s health diagnostics industry is undergoing change with increased efforts toward providing women’s reproductive health solutions.

New Testing Approaches Create Revenue Opportunities for Companies and Healthcare Providers

Complications associated with cervical cancer have led to the availability of new tests for early detection of the human papillomavirus (HPV). As such, in terms of test type, the cervical cancer testing segment of the women’s health diagnostics market is estimated to reach a value of ~US$ 12.5 Bn by 2027. Hence, companies are introducing new testing options to determine the type of HPV that may lead to cancer.

Get a glimpse of the in-depth analysis through our Report Brochure

Companies in the women’s health diagnostics business are increasing R&D to study the ‘two-for-one’ diagnostic approach that not only detects the type of HPV infection but also evaluates precancerous makers. Patients are increasingly benefitting from this approach since it serves as a low-cost alternative to diagnose the riskiest forms of HPV infection. Thus, to cater to the convenience of patients, companies in the market for women’s health diagnostics are collaborating with research labs to improve outcomes that help to avoid unnecessary diagnostic procedures. Moreover, healthcare providers are increasing efficacy in novel in-vitro molecular diagnostics procedures to assess high-risk HPV infections.
 

Optimization of Dual HIV/Syphilis Testing Serves Patient Requirement for Cost-effective Testing Options

Diagnostic laboratory centers are collaborating with renowned universities to introduce new combined HIV/syphilis testing options. For instance, Junco Labs - a provider of smartphone diagnostics, revealed its collaboration with Columbia University to demonstrate the integration of smartphone-connected blood tests for combined HIV/syphilis tests.

Thus, the diagnostic laboratories & imaging centers end-user segment of the women’s health diagnostics market is expected to reach a value of ~US$ 20.7 Bn by 2022. Hence, stakeholders in diagnostic labs are seeking innovations in dual HIV/syphilis tests.

In the global market, efforts are being made to increase the availability of point-of-care (POC) treatments for women. Companies in the women’s health diagnostics business are introducing novel testing options that provide qualitative detection of non-TP (Treponema Pallidum) syphilis. However, there is still a need for effective HIV/syphilis testing options that align with the existing target product profile (TPP). Companies in the market for women’s health diagnostics are offering cost-effective and easy-to-assess tests for combined HIV/syphilis diagnosis.

womens health diagnostics market segmentation

Expanding operations in the future? To get the perfect launch to ask for a custom report

Analysts’ Viewpoint

Companies in the women’s health diagnostics market are offering increased laboratory testing options to assess biomarkers for allergies, thyroid, and renal diseases in women. Companies should increase focus on expansion of diagnostic services in growing economies of Asia Pacific such as Indonesia and Bangladesh.

However, challenges such as poor supply chain management and stock-outs of POC diagnostic tests in developing economies, such as Ghana, pose as a challenge for manufacturing companies. Hence, companies should adopt inventory management techniques and aid health commissions to increase the human resource capacity for ensuring accessibility and sustainability toward POC testing in resource-limited settings.

Women’s Health Diagnostics Industry: Overview

  • Women’s health diagnostics are used to analyze and detect health issues in women such as breast cancer, cervical cancer, fertility & pregnancy testing, and infectious disease testing
  • The women’s health diagnostics market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market. It also provides information and data analysis of the global market with respect to segments based on device type, test type, end-user, and region
  • The overview section of the report analyzes the market dynamics and trends, such as drivers, restraints, and opportunities that influence the global market for women’s health diagnostics. The section also covers market revenue projections, market attractiveness analysis, and key market share analysis in order to provide a thorough analysis of the overall competitive scenario in the global market.

Women’s Health Diagnostics Market: Key Drivers

  • The women’s health diagnostics industry is driven by menopause, an increase in awareness among people about the availability of treatments for sexually transmitted diseases, the surge in women's health awareness, favorable incentive and reimbursement policies for UTIs, and an increase in diseases in women
  • According to the Society of Obstetricians & Gynecologists of Canada, around 80% of women claim to suffer from, at least, one menopausal symptom including mood swings, irritability, interrupted sleep, hot flushes, and vaginal dryness
  • However, the risk of breast cancer with HRT treatment, the increase in demand for alternative therapies, and legal obligations are the major factors anticipated to restrain the global market

Market Segmentation: Women’s Health Diagnostics Market

  • In terms of device type, the global market for women’s health diagnostics has been classified into biopsy devices, imaging & monitoring systems, kits & reagents, and consumables & accessories. The kits & reagents segment held a major share of the global market in 2018, as kits & reagents are used in tests such as cancer biopsy, prenatal genetic testing, and infectious disease testing.
  • Based on test type, the women’s health diagnostics market has been categorized into breast cancer testing, cervical cancer testing, prenatal genetic screening & carrier testing, pregnancy testing, fertility & ovulation testing, infectious disease testing, and others. The infectious disease testing segment dominated the market in 2018, owing to the high incidence of infectious diseases in women.
  • In terms of end users, the market for women’s health diagnostics has been divided into hospitals, diagnostic laboratories & imaging centers, specialty clinics, and others. The diagnostic laboratories & imaging centers segment accounted for a significant share of the market in 2018. The segment is expected to retain its leadership position during the forecast period. The growth of the segment can be attributed to increasing in the number of diagnostic procedures in diagnostic laboratories & imaging centers.
  • Each of the segments of the women’s health diagnostics market has been analyzed in detail for market trends, recent trends, developments, drivers, restraints, opportunities, and useful insights. The report provides current and future revenues (US$ Mn) for each of these segments for the period from 2017 to 2027, considering 2018 as the base year. The compound annual growth rate (% CAGR) has been provided for each segment and market from 2019 to 2027, along with market size estimations. 

Regional Overview: Women’s Health Diagnostics Market

  • In terms of region, the global market for women’s health diagnostics has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America accounted for a significant share of the global market in 2018. The market in the region is anticipated to be driven by the high rate of adoption of women’s health diagnostics for women’s disease analysis.
  • The study also offers a list of recommendations, highlights, and useful insights into the market, which would help new companies willing to enter the market, and existing companies to increase market shares and help in the decision-making process 

Major Players in Global Market

  • The women’s health diagnostics report concludes with the company profiles section that includes key information about the major players in the market
  • Key players operating in the global women’s health diagnostics business include
    • Abbott Laboratories
    • Becton
    • Dickinson and Company
    • bioMérieux SA
    • F. Hoffmann-La Roche AG
    • GE Healthcare
    • Hologic, Inc.
    • Koninklijke Philips N.V.
    • Quest Diagnostics Inc.
    • Cardinal Health
    • Siemens AG 

Women’s Health Diagnostics Market – Segmentation

Device Type

Biopsy Devices

Imaging & Monitoring Systems

  • Ultrasound Devices
  • Mammography Systems
  • MRI Systems
  • Others

Kits & Reagents

Consumables & Accessories

Test Type

Breast Cancer Testing

Cervical Cancer Testing

Prenatal Genetic Screening & Carrier Testing

Pregnancy Testing

Fertility & Ovulation Testing

Infectious Disease Testing

Others

End User

Hospitals

Diagnostic Laboratories & Imaging Centers

Specialty Clinics

Others

Region

North America  

Europe

Asia Pacific     

Latin America   

Middle East & Africa

Women’s Health Diagnostics Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of women’s health diagnostics market?

The global market for Women’s health diagnostics is projected to reach a value of ~US$ 19.2 Bn by the end of 2027

What is the anticipated CAGR of the women’s health diagnostic market in the forecast period?

The market is projected to expand at a CAGR of ~6% from 2019 to 2027

What are the key driving factors for the growth of the women’s health diagnostics business?

Women’s health diagnostics market is driven by increase in awareness among people about the availability of treatments for sexually transmitted diseases

What are the end-use segments in the global market for women’s health diagnostics?

The end-use segments in women’s health diagnostics market are hospitals, diagnostic laboratories & imaging centers and specialty clinics

Who are the key players in the women’s health diagnostics industry?

Key players in the global market for women’s health diagnostics include Abbott Laboratories, Becton, Dickinson and Company, bioMérieux SA, F. Hoffmann-La Roche AG

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. 3. Executive Summary: Global Women’s Health Diagnostics Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Women’s Health Diagnostics Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

5. Global Women’s Health Diagnostics Market Analysis and Forecast, by Device Type 

    5.1. Introduction

    5.2. Key Findings

    5.3. Global Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027

        5.3.1. Biopsy Devices

        5.3.2. Imaging & Monitoring System

            5.3.2.1. Ultrasound Devices

            5.3.2.2. Mammography Systems

            5.3.2.3. MRI Systems

            5.3.2.4. Others

        5.3.3. Kits & Reagents

        5.3.4. Consumables & Accessories

    5.4. Global Women’s Health Diagnostics Market Attractiveness, by Device Type 

6. Global Women’s Health Diagnostics Market Analysis and Forecast, by Test Type

    6.1. Introduction & Definition

    6.2. Key Findings 

    6.3. Global Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027

        6.3.1. Breast Cancer Testing

        6.3.2. Cervical Cancer Testing

        6.3.3. Prenatal Genetic Screening & Carrier Testing

        6.3.4. Pregnancy Testing

        6.3.5. Fertility & Ovulation Testing

        6.3.6. Infectious Disease Testing

        6.3.7. Others

    6.4. Global Women’s Health Diagnostics Market Attractiveness, by Test Type

7. Global Women’s Health Diagnostics Market Analysis and Forecast, by End-user 

    7.1. Introduction

    7.2. Key Findings

    7.3. Global Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027

        7.3.1. Hospitals

        7.3.2. Diagnostic Laboratories & Imaging Centers

        7.3.3. Specialty Clinics

        7.3.4. Others 

    7.4. Global Women’s Health Diagnostics Market Attractiveness, by End-user 

8. Global Women’s Health Diagnostics Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Global Women’s Health Diagnostics Market Value Forecast, by Region, 2017–2027

        8.2.1. North America 

        8.2.2. Europe 

        8.2.3. Asia Pacific 

        8.2.4. Latin America 

        8.2.5. Middle East & Africa 

    8.3. Global Women’s Health Diagnostics Market Attractiveness, by Region

9. North America Women’s Health Diagnostics Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. North America Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027

        9.2.1. Biopsy Devices

        9.2.2. Imaging & Monitoring System

            9.2.2.1. Ultrasound Devices

            9.2.2.2. Mammography Systems

            9.2.2.3. MRI Systems

            9.2.2.4. Others

        9.2.3. Kits & Reagents

        9.2.4. Consumables & Accessories

    9.3. North America Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027

        9.3.1. Breast Cancer Testing

        9.3.2. Cervical Cancer Testing

        9.3.3. Prenatal Genetic Screening & Carrier Testing

        9.3.4. Pregnancy Testing

        9.3.5. Fertility & Ovulation Testing

        9.3.6. Infectious Disease Testing

        9.3.7. Others

    9.4. North America Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027

        9.4.1. Hospitals

        9.4.2. Diagnostic Laboratories & Imaging Centers

        9.4.3. Specialty Clinics

        9.4.4. Others

    9.5. North America Women’s Health Diagnostics Market Value Forecast, by Country, 2017–2027

        9.5.1. U.S.

        9.5.2. Canada

    9.6. North America Women’s Health Diagnostics Market Attractiveness Analysis 

        9.6.1. By Device Type 

        9.6.2. By Test Type 

        9.6.3. By End-user 

        9.6.4. By Country

10. Europe Women’s Health Diagnostics Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Europe Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027

        10.2.1. Biopsy Devices

        10.2.2. Imaging & Monitoring System

            10.2.2.1. Ultrasound Devices

            10.2.2.2. Mammography Systems

            10.2.2.3. MRI Systems

            10.2.2.4. Others

        10.2.3. Kits & Reagents

        10.2.4. Consumables & Accessories

    10.3. Europe Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027

        10.3.1. Breast Cancer Testing

        10.3.2. Cervical Cancer Testing

        10.3.3. Prenatal Genetic Screening & Carrier Testing

        10.3.4. Pregnancy Testing

        10.3.5. Fertility & Ovulation Testing

        10.3.6. Infectious Disease Testing

        10.3.7. Others

    10.4. Europe Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027

        10.4.1. Hospitals

        10.4.2. Diagnostic Laboratories & Imaging Centers

        10.4.3. Specialty Clinics

        10.4.4. Others

    10.5. Europe Women’s Health Diagnostics Market Value Forecast, by Country/Sub-region, 2017–2027

        10.5.1. Germany

        10.5.2. U.K.

        10.5.3. France

        10.5.4. Spain

        10.5.5. Italy

        10.5.6. Rest of Europe

    10.6. Europe Women’s Health Diagnostics Market Attractiveness Analysis 

        10.6.1. By Device Type 

        10.6.2. By Test Type

        10.6.3. By End-user 

        10.6.4. By Country/Sub-region

11. Asia Pacific Women’s Health Diagnostics Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Asia Pacific Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027

        11.2.1. Biopsy Devices

        11.2.2. Imaging & Monitoring System

            11.2.2.1. Ultrasound Devices

            11.2.2.2. Mammography Systems

            11.2.2.3. MRI Systems

            11.2.2.4. Others

        11.2.3. Kits & Reagents

        11.2.4. Consumables & Accessories

    11.3. Asia Pacific Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027

        11.3.1. Breast Cancer Testing

        11.3.2. Cervical Cancer Testing

        11.3.3. Prenatal Genetic Screening & Carrier Testing

        11.3.4. Pregnancy Testing

        11.3.5. Fertility & Ovulation Testing

        11.3.6. Infectious Disease Testing

        11.3.7. Others

    11.4. Asia Pacific Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027

        11.4.1. Hospitals

        11.4.2. Diagnostic Laboratories & Imaging Centers

        11.4.3. Specialty Clinics

        11.4.4. Others

    11.5. Asia Pacific Women’s Health Diagnostics Market Value Forecast, by Country/Sub-region, 2017–2027

        11.5.1. China

        11.5.2. Japan

        11.5.3. India

        11.5.4. Australia & New Zealand

        11.5.5. Rest of Asia Pacific

    11.6. Asia Pacific Women’s Health Diagnostics Market Attractiveness Analysis 

        11.6.1. By Device Type 

        11.6.2. By Test Type 

        11.6.3. By End-user 

        11.6.4. By Country/Sub-region

12. Latin America Women’s Health Diagnostics Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Latin America Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027

        12.2.1. Biopsy Devices

        12.2.2. Imaging & Monitoring System

            12.2.2.1. Ultrasound Devices

            12.2.2.2. Mammography Systems

            12.2.2.3. MRI Systems

            12.2.2.4. Others

        12.2.3. Kits & Reagents

        12.2.4. Consumables & Accessories

    12.3. Latin America Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027

        12.3.1. Breast Cancer Testing

        12.3.2. Cervical Cancer Testing

        12.3.3. Prenatal Genetic Screening & Carrier Testing

        12.3.4. Pregnancy Testing

        12.3.5. Fertility & Ovulation Testing

        12.3.6. Infectious Disease Testing

        12.3.7. Others

    12.4. Latin America Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027

        12.4.1. Hospitals

        12.4.2. Diagnostic Laboratories & Imaging Centers

        12.4.3. Specialty Clinics

        12.4.4. Others

    12.5. Latin America Women’s Health Diagnostics Market Attractiveness Analysis 

        12.5.1. By Device Type 

        12.5.2. By Test Type 

        12.5.3. By End-user 

        12.5.4. By Country/Sub-region

13. Middle East & Africa Women’s Health Diagnostics Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Middle East & Africa Women’s Health Diagnostics Market Value Forecast, by Device Type, 2017–2027

        13.2.1. Biopsy Devices

        13.2.2. Imaging & Monitoring System

            13.2.2.1. Ultrasound Devices

            13.2.2.2. Mammography Systems

            13.2.2.3. MRI Systems

            13.2.2.4. Others

        13.2.3. Kits & Reagents

        13.2.4. Consumables & Accessories

    13.3. Middle East & Africa Women’s Health Diagnostics Market Value Forecast, by Test Type, 2017–2027

        13.3.1. Breast Cancer Testing

        13.3.2. Cervical Cancer Testing

        13.3.3. Prenatal Genetic Screening & Carrier Testing

        13.3.4. Pregnancy Testing

        13.3.5. Fertility & Ovulation Testing

        13.3.6. Infectious Disease Testing

        13.3.7. Others

    13.4. Middle East & Africa Women’s Health Diagnostics Market Value Forecast, by End-user, 2017–2027

        13.4.1. Hospitals

        13.4.2. Diagnostic Laboratories & Imaging Centers

        13.4.3. Specialty Clinics

        13.4.4. Others 

    13.5. Middle East & Africa Women’s Health Diagnostics Market Value Forecast, by Country/Sub-region, 2017–2027

        13.5.1. GCC Countries

        13.5.2. South Africa

        13.5.3. Rest of Middle East & Africa

    13.6. Middle East & Africa Women’s Health Diagnostics Market Attractiveness Analysis 

        13.6.1. By Device Type 

        13.6.2. By Test Type

        13.6.3. By End-user 

        13.6.4. By Country/Sub-region

14. Competition Landscape

    14.1. Market Players - Competition Matrix (By Tier and Size of companies)

    14.2. Market Share Analysis, by Company, 2018

    14.3. Company Profiles

        14.3.1. Abbott Laboratories 

            14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.1.2. Financial Overview

            14.3.1.3. Product Portfolio

            14.3.1.4. SWOT Analysis 

            14.3.1.5. Strategic Overview

        14.3.2. Becton, Dickinson and Company

            14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.2.2. Financial Overview

            14.3.2.3. Product Portfolio

            14.3.2.4. SWOT Analysis 

            14.3.2.5. Strategic Overview

        14.3.3. bioMérieux SA

            14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.3.2. Financial Overview

            14.3.3.3. Product Portfolio

            14.3.3.4. SWOT Analysis 

            14.3.3.5. Strategic Overview

        14.3.4. F. Hoffmann-La Roche AG

            14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.4.2. Financial Overview

            14.3.4.3. Product Portfolio

            14.3.4.4. SWOT Analysis 

            14.3.4.5. Strategic Overview

        14.3.5. GE Healthcare

            14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.5.2. Financial Overview

            14.3.5.3. Product Portfolio

            14.3.5.4. SWOT Analysis 

            14.3.5.5. Strategic Overview

        14.3.6. Hologic, Inc.

            14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.6.2. Financial Overview

            14.3.6.3. Product Portfolio

            14.3.6.4. SWOT Analysis 

            14.3.6.5. Strategic Overview

        14.3.7. Koninklijke Philips N.V.

            14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.7.2. Financial Overview

            14.3.7.3. Product Portfolio

            14.3.7.4. SWOT Analysis 

            14.3.7.5. Strategic Overview

        14.3.8. Quest Diagnostics, Inc.

            14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.8.2. Financial Overview

            14.3.8.3. Product Portfolio

            14.3.8.4. SWOT Analysis 

            14.3.8.5. Strategic Overview

        14.3.9. Cardinal Health

            14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.9.2. Financial Overview

            14.3.9.3. Product Portfolio

            14.3.9.4. SWOT Analysis 

            14.3.9.5. Strategic Overview

        14.3.10. Siemens AG

            14.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.3.10.2. Financial Overview

            14.3.10.3. Product Portfolio

            14.3.10.4. SWOT Analysis 

            14.3.10.5. Strategic Overview

List of Tables

Table 01: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027

Table 02: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring Systems, 2017–2027

Table 03: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 04: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 05: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 06: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country, 2017–2027

Table 07: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027

Table 08: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System

Table 09: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 10: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 11: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 12: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027

Table 13: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System

Table 14: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 15: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 16: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 17: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027

Table 18: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System

Table 19: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 20: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 21: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 22: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027

Table 23: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System

Table 24: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 25: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027

Table 26: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 27: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Device Type, 2017–2027

Table 28: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Imaging and Monitoring System

Table 29: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by Test Type, 2017–2027

Table 30: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, by End-user, 2017–2027

List of Figures

Figure 01: Global Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017–2027

Figure 02: Global Women's Health Diagnostics Market Value Share by Device Type (2018)

Figure 03: Global Women's Health Diagnostics Market Value Share by End-users (2018)

Figure 04: Global Women's Health Diagnostics Market Value Share by Test Type (2018)

Figure 05: Global Women's Health Diagnostics Market Value Share by Region (2018)

Figure 06: Global Women's Health Diagnostics Market Value Share, by Device Type, 2018 and 2027

Figure 07: Global Women's Health Diagnostics Market Attractiveness, by Device Type, 2018

Figure 08: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Biopsy Devices, 2017–2027

Figure 09: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Imaging and Monitoring Systems, 2017–2027

Figure 10: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Kits & Reagents, 2017–2027

Figure 11: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Consumables & Accessories, 2017–2027

Figure 12: Global Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 13: Global Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018

Figure 14: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Breast Cancer Testing, 2017–2027

Figure 15: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Cervical Cancer Testing, 2017- 2027

Figure 16: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Prenatal Genetic Screening and Carrier Testing, 2017–2027

Figure 17: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Pregnancy Testing, 2017- 2027

Figure 18: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Fertility and Ovulation Testing, 2017–2027

Figure 19: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Infectious Disease Testing, 2017- 2027

Figure 20: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 21: Global Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 22: Global Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018

Figure 23: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027

Figure 24: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Diagnostic Laboratories & Imaging Centers, 2017–2027

Figure 25: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017–2027

Figure 26: Global Women's Health Diagnostics Market Value (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 27: Global Women's Health Diagnostics Market Value Share Analysis, by Region, 2018 and 2027

Figure 28: Global Women's Health Diagnostics Market Attractiveness Analysis, by Region, 2018

Figure 29: North America Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017–2027

Figure 30: North America Women's Health Diagnostics Market Attractiveness Analysis, by Country, 2018

Figure 31: North America Women's Health Diagnostics Market Value Share Analysis, by Country, 2018 and 2027

Figure 32: North America Women's Health Diagnostics Market Value Share Analysis, by Device Type, 2018 and 2027

Figure 33: North America Women's Health Diagnostics Market Attractiveness, by Device Type, 2018

Figure 34: North America Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 35: North America Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018

Figure 36: North America Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 37: North America Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018

Figure 38: Europe Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017–2027

Figure 39: Europe Women's Health Diagnostics Market Attractiveness, by Country/Sub-region, 2018

Figure 40: Europe Women's Health Diagnostics Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 41: Europe Women's Health Diagnostics Market Value Share Analysis, by Device Type, 2018 and 2027

Figure 42: Europe Women's Health Diagnostics Market Attractiveness, by Device Type, 2018

Figure 43: Europe Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 44: Europe Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018

Figure 45: Europe Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 46: Europe Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018

Figure 47: Asia Pacific Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017–2027

Figure 48: Asia Pacific Women's Health Diagnostics Market Attractiveness Analysis, by Country/Sub-region, 2018

Figure 49: Asia Pacific Women's Health Diagnostics Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 50: Asia Pacific Women's Health Diagnostics Market Value Share Analysis, by Device Type, 2018 and 2027

Figure 51: Asia Pacific Women's Health Diagnostics Market Attractiveness, by Device Type, 2018

Figure 52: Asia Pacific Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 53: Asia Pacific Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018

Figure 54: Asia Pacific Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 55: Asia Pacific Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018

Figure 56: Latin America Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017–2027

Figure 57: Latin America Women's Health Diagnostics Market Attractiveness, by Country/Sub-region, 2018

Figure 58: Latin America Women's Health Diagnostics Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 59: Latin America Women's Health Diagnostics Market Value Share Analysis, by Device Type, 2018 and 2027

Figure 60: Latin America Women's Health Diagnostics Market Attractiveness, by Device Type, 2018

Figure 61: Latin America Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 62: Latin America Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018

Figure 63: Latin America Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 64: Latin America Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018

Figure 65: Middle East & Africa Women's Health Diagnostics Market Value (US$ Mn) Forecast, 2017–2027

Figure 66: Middle East & Africa Women's Health Diagnostics Market Attractiveness, by Country/Sub-region, 2018

Figure 67: Middle East & Africa Women's Health Diagnostics Market Value Share, by Country/Sub-region, 2018 and 2027

Figure 68: Middle East & Africa Women's Health Diagnostics Market Value Share Analysis, by Device Type, 2018 and 2027

Figure 69: Middle East & Africa Women's Health Diagnostics Market Attractiveness, by Device Type, 2018

Figure 70: Middle East & Africa Women's Health Diagnostics Market Value Share Analysis, by Test Type, 2018 and 2027

Figure 71: Middle East & Africa Women's Health Diagnostics Market Attractiveness Analysis, by Test Type, 2018

Figure 72: Middle East & Africa Women's Health Diagnostics Market Value Share Analysis, by End-user, 2018 and 2027

Figure 73: Middle East & Africa Women's Health Diagnostics Market Attractiveness Analysis, by End-user, 2018

Figure 74: Global Women's Health Diagnostics Market Share Analysis, by Company (2018)

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

563

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved